Wandercraft

What Wandercraft does

Wandercraft is a French robotics company that develops self-balancing walking exoskeletons and humanoid robots, founded in 2012 in Paris by Nicolas Simon, Matthieu Masselin, Jean-Louis Constanza, and Alexandre Boulanger. The company operates three core products built on a shared technology platform: Atalante X, a self-balancing rehabilitation exoskeleton used in hospitals; Eve, a personal exoskeleton for individuals with walking impairments designed for home and outdoor use; and Calvin-40, a heavy-duty industrial humanoid robot for factory and logistics applications. Its underlying technology combines 12+ years of proprietary self-balancing algorithms, 12 degrees of freedom with 12 motors, sensor arrays, and AI-driven real-time adaptation powered by NVIDIA and AWS compute, which the company states has been refined through billions of AI simulations.

The company's revenue model is anchored in capital equipment sales of medical exoskeletons priced in the USD 70,000–150,000 range per unit, deployed across more than 100 rehabilitation institutions globally in Europe, the United States, Brazil, and Australia. A secondary revenue stream is emerging from the sale and deployment of Calvin-40 humanoid robots under industrial partnerships with Renault Group (with plans for 350 units across Renault's French facilities) and SAPA. Additional revenue mechanics include clinical trial services supporting the Eve personal exoskeleton pivotal studies, and "Walk as a Service" trial sessions at company-operated Walk in Paris and Walk in New York centers. Customer segments are split across rehabilitation hospitals and neurology centers (primary), industrial manufacturing (Renault, SAPA), and individuals with mobility impairments (future Eve consumer market). Go-to-market combines direct enterprise field sales to hospitals with industrial channel partnerships and clinical-trial-led community adoption.

Name

Wandercraft

Legal name

Wandercraft

Website

https://en.wandercraft.eu

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Wandercraft is a Paris-based robotics company developing self-balancing walking exoskeletons for medical rehabilitation and personal mobility, plus industrial humanoid robots for manufacturing and logistics, serving hospitals, industrial partners like Renault, and individuals with walking impairments.

Ownership category

akta.pro rank

Product category

Medical Robotics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Healthcare & Assistive Robotics (HDAAAIAC)

akta.pro secondary industries

Humanoid & General-Purpose Robots (HDAAAIAJ), Mobility Aids (Wheelchairs, Scooters, Walkers, Canes) (HLAHAMAA), Robot Hardware, Actuators & Components (sensors, grippers, motors) (HDAAAIAL)

Keywords

• Rehabilitation exoskeletons
• Medical robotics
• Humanoid robots
• Personal mobility devices
• Industrial automation

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Exoskeleton Sales: Sale of Atalante X rehabilitation exoskeletons to hospitals and rehabilitation centers worldwide. Atalante X commercialized since 2019, deployed in nearly 100 rehabilitation institutions globally.
2. Industrial Humanoid Robotics: Sale and deployment of Calvin-40 humanoid robots to industrial partners including Renault Group and SAPA for manufacturing and logistics applications.
3. Walk as a Service (WaaS): Trial sessions at Walk in Paris and Walk in New York centers offering patients access to exoskeleton technology with multidisciplinary therapeutic support.
4. Clinical Trial Services: Pivotal clinical trials evaluating Personal Exoskeleton for individuals with spinal cord injuries at major US medical centers.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Wandercraft develops and manufactures autonomous self-balancing walking exoskeletons and humanoid robots. Its commercial medical product Atalante X is a rehabilitation exoskeleton for hospitals, the Eve personal exoskeleton enables hands-free walking for individuals with mobility impairments at home and outdoors, and the Calvin-40 is an industrial humanoid robot for manufacturing and logistics. The company sells these robotic systems directly to hospitals and industrial partners, and operates trial centers for patient access.

Product overview

Wandercraft develops, manufactures, and markets autonomous walking exoskeletons and humanoid robots. The company offers three distinct products: Atalante X (rehabilitation exoskeleton for hospitals), Eve (personal exoskeleton for home use), and Calvin-40 (industrial humanoid robot). Atalante X and Eve share self-balancing technology enabling hands-free walking, while Calvin-40 applies the same robotics expertise to industrial logistics. The product portfolio spans healthcare rehabilitation, personal mobility, and industrial automation, all built on shared engineering DNA in dynamic walking algorithms and high-performance robotics.

Differentiator

Problem solved

Functional benefit

Brands

• Atalante X: Self-balancing exoskeleton for gait training in rehabilitation centers, used in hospitals across Europe, USA, and Brazil.
• Eve
• Calvin-40
• Walk in Paris
• Walk in New York

Products and services

• Atalante X Self-balancing, hands-free, multi-directional gait and balance exoskeleton for rehabilitation. Enables patients with severe mobility impairments to walk hands-free without crutches. FDA cleared for stroke (December 2022) and spinal cord injury (February 2024) rehabilitation; CE marked as Class IIa medical device. Deployed in 100+ rehabilitation institutions globally.
• Eve The first self-balancing personal exoskeleton that does not require crutches. Designed for individuals with walking impairments to stand and move independently both indoors and outdoors. Features 12 degrees of freedom and 12 motors. Currently in clinical trials (Kessler Foundation, James J. Peters VA Medical Center) with plans for commercial availability.
• Calvin-40 Heavy-duty autonomous humanoid robot for industrial applications. Moves heavy loads, handles boxes and crates, and picks small parts with precision. The first industrial humanoid launched in Europe, developed in collaboration with Renault Group. Hundreds of units ordered for factories and logistics hubs.
• Walk in Paris Company-operated trial center in Paris offering Atalante X sessions with physiotherapists and occupational therapists. Provides patients with mobility disabilities the opportunity to stand, walk, and take part in adapted physical activities.

Quantifiable outcome

• Over 1 million steps taken monthly by users of Wandercraft exoskeletons
• +4 more outcomes

Named customers12 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

Eight partnerships are on record, tiered core, flagship and minor.

• SAPAcoreStrategic or Co-development Partner · 12 November 2025Deployment partnership to implement and scale Calvin-40 humanoid robot in SAPA's industrial operations, with planned deployments in two countries. Marks Europe's emergence in humanoid robotics race.
• Renault GroupcoreStrategic or Co-development Partner · 6 June 2025Strategic partnership with minority investment from Renault Group to develop and scale humanoid robots for industrial manufacturing. Includes development of Calvin-40 humanoid robot for Renault factories. Plans to deploy 350 humanoid robots across Renault manufacturing facilities in France within 18 months.
• NVIDIAflagshipTechnology or Integration · 7 January 2025Featured in NVIDIA CES 2025 keynote by Jensen Huang. Personal Exoskeleton uses NVIDIA AI-driven computing power for real-time adaptability. Collaboration powers billions of AI simulations for safety and reliability improvement.
• AWS (Amazon Web Services)flagshipTechnology or IntegrationPartnership with NVIDIA and AWS at GTC 2025 conference. AWS infrastructure supporting AI computing for exoskeleton technology. Included in Physical AI Fellowship powered by AWS, NVIDIA, and MassRobotics.
• APF France handicapminorStrategic or Co-development PartnerPartnership to launch survey of potential future users for new generation exoskeleton development. APF France handicap represents people with disabilities, providing valuable user insights.
• James J. Peters VA Medical CentercoreStrategic or Co-development PartnerClinical trial site for Personal Exoskeleton pivotal trial in Bronx, NY. Dr. Ann M. Spungen leading spinal cord damage research at this VA facility.
• Kessler FoundationcoreStrategic or Co-development PartnerClinical trial site and research partner for Atalante X and Personal Exoskeleton studies. Gail Forrest, PhD, Director of Tim and Caroline Reynolds Center for Spinal Stimulation.
• PermobilminorStrategic or Co-development PartnerAppointed Permobil CEO Chuck Witkowski to Board of Directors, signaling new phase of growth and global commercialization for mobility solutions.

Scale indicators13 records

Recent moves2 records

Expansion highlights7 records

Direct peers

• Ekso Bionics: Ekso Bionics develops Ekso GT and other rehabilitation exoskeletons for stroke and spinal cord injury gait training. Direct competitor to Wandercraft's Atalante X in hospital-based exoskeleton rehab, serving similar patient populations and clinical settings.
• ReWalk Robotics: ReWalk Robotics is a pioneer in personal and rehabilitation exoskeletons (ReWalk Personal 6.0 and ReStore). Closest direct competitor to Wandercraft in both clinical rehabilitation and personal/consumer exoskeleton use cases for spinal cord injury patients.
• Parker Hannifin (Indego): Parker Hannifin's Indego division makes modular lower-limb exoskeletons for clinical and personal use. Directly competes with Atalante X in rehabilitation hospitals and with Eve in the personal exoskeleton segment.
• Cyberdyne: Cyberdyne's HAL (Hybrid Assistive Limb) is one of the most established exoskeletons globally, used for rehabilitation in Japan and select international markets. Comparable to Wandercraft's Atalante X for gait training, with different bioelectrical signal-based control approach.
• Rex Bionics: Rex Bionics makes hands-free, self-supporting exoskeletons (REX) for individuals with mobility impairments. Direct competitor in the hands-free exoskeleton category, particularly focused on personal use cases overlapping with Wandercraft's Eve.

Emerging players

• Tesla (Optimus): Tesla's Optimus humanoid robot targets industrial and eventually domestic use. While not yet deployed at scale, Tesla's capital, manufacturing scale and AI capabilities make it a credible competitor to Wandercraft's Calvin-40 in factory deployments with automotive OEMs.
• Agility Robotics: Agility Robotics develops Digit, a bipedal humanoid robot for logistics and warehouse automation. Comparable to Wandercraft's Calvin-40 in bipedal humanoid form factor for industrial applications, with established partnerships with Amazon and GXO.
• Figure AI: Figure AI builds general-purpose humanoid robots (Figure 01/02) targeting industrial and commercial use, with BMW and OpenAI partnerships. Direct emerging competitor to Calvin-40 in factory humanoid robotics with similar industrial OEM partnerships.
• 1X Technologies: 1X Technologies (backed by OpenAI) develops the Neo bipedal humanoid robot for home and commercial use. Comparable to Wandercraft's strategic direction toward personal mobility applications (Eve), though targeting general-purpose domestic robotics rather than medical exoskeletons.

Broad incumbents

• Boston Dynamics: Boston Dynamics (owned by Hyundai) develops Atlas and Spot, advanced humanoid and quadrupedal robots. While focused on broader robotics applications rather than medical exoskeletons, it represents a well-capitalized incumbent that could expand into mobility/walking aid territory overlapping with Wandercraft.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ExoWandercraft
• YouTubeyoutube.com/channel/UCWmhQuUMF87d-vSrRe1-_9A
• Facebookfacebook.com/wandercraft.eu
• LinkedInlinkedin.com/company/wandercraft
• Instagraminstagram.com/wandercraft.official

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds9 records

Investors24 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wandercraft